tiprankstipranks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market

Vir Biotechnology (VIR) Income Statement

Compare
1,337 Followers

Vir Biotechnology Income Statement

Last quarter (Q3 2024), Vir Biotechnology's total revenue was $2.38M, a decrease of -158.08% from the same quarter last year. In Q3, Vir Biotechnology's net income was $-213.72M. See Vir Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 86.18M$ 1.58B$ 1.09B$ 67.25M$ 711.00K
Gross Profit
$ 83.42M$ 1.43B$ 1.02B$ -234.33M$ -147.76M
Operating Expenses
$ 767.72M$ 601.09M$ 600.45M$ 364.23M$ 178.69M
Depreciation and Amortization
$ 19.45M$ 15.49M$ 11.98M$ 8.81M$ 4.52M
EBITDA
$ -664.85M$ 833.07M$ 420.75M$ -289.80M$ -173.46M
Operating Income
$ -684.30M$ 833.07M$ 276.89M$ -296.98M$ -177.98M
Other Income/Expenses
$ 56.11M$ -78.79M$ 129.05M$ -1.63M$ 3.45M
Pretax Income
$ -628.19M$ 754.28M$ 549.80M$ -298.61M$ -174.53M
Net Income
$ -615.06M$ 515.84M$ 528.58M$ -298.67M$ -174.68M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.59$ 3.89$ 4.07$ -2.51$ -1.62
Diluted EPS
$ -4.59$ 3.83$ 3.96$ -2.51$ -1.62
Weighted Average Shares Outstanding
134.13M 132.61M 129.88M 119.16M 107.65M
Weighted Average Shares Outstanding (Diluted)
134.13M 134.81M 133.44M 119.16M 107.65M
Currency in USD

Vir Biotechnology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis